The Radionuclide Dosimetry Group (INSERM unit 892) is located within the University Hospital and is the research core of the Regional Oncology Institute (Institut Régional de Cancérologie Nantes Atlantique IRCNA), an entity that also joins together several clinical oncology departments from the Nantes Cancer Centre (CLCC) and Nantes University Hospital (CHUN).
Partner no. 3 will be responsible for WP 4, whose objectives are to list existing anthropomorphic phantoms that are or have been proposed as a basis for radiopharmaceutical dosimetry, to
review phantom parameters (i.e. height, weight, sampling resolution,
number and characteristics of considered organs), to establish a list
of modelling approaches that have been considered thus far, to assess
the impact of geometry definition on dosimetric results, to assess the impact of pharmacokinetics assumptions on dosimetric results and to derive a list of radiopharmaceuticals that would require an optimised dosimetric assessment.